Reaction
Microvascular Coronary Artery Disease reporting signals
As of the last recalculation, Microvascular Coronary Artery Disease appears in 207 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 151.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ado-Trastuzumab Emtansine | 12 | 151.9 | 152.1 |
| Ranolazine | 10 | 101.2 | 101.3 |
| Pemetrexed | 12 | 59.7 | 59.7 |
| Pertuzumab | 13 | 51.2 | 51.3 |